2020年12月28日,Elevar Therapeutics宣布与Inceptua Group达成在欧洲分销和商业化Apealea®(紫杉醇胶束)的独家协议。Apealea已获得欧洲监管机构批准,与卡铂联用治疗首次复发的铂敏感性上皮性卵巢癌、原发性腹膜癌、输卵管癌成人患者。根据协...查看全文
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-14 AccNo: 0001144204-17-032517 Size: 28 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-13 AccNo: 0001144204-17-032336 Size: 47 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-09 AccNo: 0001144204-17-031815 Size: 536 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-05 AccNo: 0001144204-17-031001 Size: 35 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-31 AccNo: 0001144204-17-030373 Size: 23 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-11 AccNo: 0001144204-17-026443 Size: 28 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-02 AccNo: 0001144204-17-023921 Size: 33 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-04-25 AccNo: 0001144204-17-021974 Size: 25 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-04-18 AccNo: 0001144204-17-020899 Size: 27 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-03-31 AccNo: 0001144204-17-018161 Size: 28 KB 网页链接